In de overschakelingsstudie waren er meer patiënten die reageerden op de behandeling met Tasmar (53%) dan op de behandeling met entacapon (43%). ###>In the switch study, there were more patients who responded to treatment with Tasmar (53%) than to treatment with entacapone (43%).